Company Filing History:
Years Active: 2009-2010
Title: The Innovative Contributions of Xianming Huang in Cancer Treatment
Introduction: Xianming Huang, based in Dallas, TX, has made significant contributions to the field of cancer treatment through his innovative research and patents. As an accomplished inventor, Huang holds three patents that explore the intricate relationship between aminophospholipids, anionic phospholipids, and their implications in cancer and viral infections.
Latest Patents: Huang's latest patents demonstrate groundbreaking discoveries that enhance our understanding of tumor vasculature and the mechanisms of viral entry and spread. One of his notable patents focuses on combinations and kits for cancer treatment utilizing selected antibodies to target aminophospholipids. This work reveals compositions and methods designed to leverage these findings for effective cancer and viral infection treatment. Additionally, his patent on liposomes coated with selected antibodies similarly explores these novel interactions and proposes advantageous compositions for safe and effective therapeutic applications.
Career Highlights: Xianming Huang is affiliated with the University of Texas System, where he conducts vital research that pushes the boundaries of current medical understanding. His work has substantial implications for the development of innovative therapeutic strategies in the fight against cancer and viral diseases.
Collaborations: Huang collaborates with esteemed colleagues such as Philip E. Thorpe and Sophia Ran, who contribute to the multidisciplinary approach required for such complex research. Their collective expertise facilitates the advancement of knowledge and the development of new treatment modalities.
Conclusion: Xianming Huang's contributions to the field of cancer treatment exemplify the power of innovation in medical research. His patents not only provide insights into critical biological processes but also pave the way for the development of novel therapies. As research continues, Huang's work will undoubtedly play a pivotal role in improving outcomes for patients battling cancer and viral infections.